Open : Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-up in the PYRAMID Registry

D'Haens G., Reinisch W., Panaccione R., Satsangi J., Petersson J., Bereswill M., Arikan D., Perotti E., Robinson AM., Kalabic J., Alperovich G., Thakkar R., Loftus EV.

DOI

10.1038/s41395-018-0098-4

Type

Journal article

Journal

American Journal of Gastroenterology

Publisher

Ovid Technologies (Wolters Kluwer Health)

Publication Date

06/2018

Volume

113

Pages

872 - 882

Permalink Original publication